Funding Round Open – 18 May 2020
Date closing – 1 June 2020
We am pleased to announce that MTPConnect is set to launch a new round of its Biomedical Translation Bridge (BTB) program, specifically designed to target COVID-19 related research.
Eligible organisations can apply for up to $1 million of matching funding for research to develop medical devices, diagnostics, prophylactic or therapeutic approaches that will achieve an impact in 12-months or less.
Expressions of Interest (EOIs) will be open for just two weeks from Monday 18 May – Monday 1 June 2020. Funding will support Australian small and medium enterprises, medical research institutes and universities conducting COVID-19 related research projects.
We have designed the BTB rapid response COVID-19 funding round to get results as quickly as possible to help protect the health of Australians and other communities through the earliest possible deployment of new vaccines, therapeutics, diagnostics and medical devices.
We operate the BTB program, an initiative of the Medical Research Future Fund, in partnership with BioCurate, UniQuest, the Medical Device Partnering Program (MDPP) and the Bridge and BridgeTech programs (Queensland University of Technology).
All the information you need to support an application can be found on the BTB page.
If you have any questions, please contact Lauren Kelly, our Director of the BTB program.